Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIB Study of Novel Quantitative Neurodiagnostic Technology in the Early Period After Cardiac Arrest

NCT00483873 is registered in ClinicalTrials.gov with Infinite Biomedical Technologies as lead sponsor.

NCT NCT00483873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00483873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIB Study of Novel Quantitative Neurodiagnostic Technology in the Early Period After Cardiac Arrest
Lead sponsor
Infinite Biomedical Technologies
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2007
Completion date
December 31, 2009
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, cardiac arrest